000 01579 a2200409 4500
005 20250513154729.0
264 0 _c19981130
008 199811s 0 0 eng d
022 _a0732-183X
024 7 _a10.1200/JCO.1998.16.11.3518
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMehta, M P
245 0 0 _aPhase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: results of Eastern Cooperative Oncology Group 4593.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cNov 1998
300 _a3518-23 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
650 0 4 _aAged
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xradiotherapy
650 0 4 _aDose Fractionation, Radiation
650 0 4 _aEsophagitis
_xetiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xradiotherapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRadiotherapy
_xadverse effects
650 0 4 _aTreatment Outcome
700 1 _aTannehill, S P
700 1 _aAdak, S
700 1 _aMartin, L
700 1 _aPetereit, D G
700 1 _aWagner, H
700 1 _aFowler, J F
700 1 _aJohnson, D
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 16
_gno. 11
_gp. 3518-23
856 4 0 _uhttps://doi.org/10.1200/JCO.1998.16.11.3518
_zAvailable from publisher's website
999 _c9781479
_d9781479